Last reviewed · How we verify
Loxonine tab.
Loxonine is a prodrug that is converted to its active form to inhibit platelet aggregation and provide anticoagulant effects.
Loxonine is a prodrug that is converted to its active form to inhibit platelet aggregation and provide anticoagulant effects. Used for Thrombotic disorders, Stroke prevention, Peripheral arterial disease.
At a glance
| Generic name | Loxonine tab. |
|---|---|
| Also known as | Loxoprofen |
| Sponsor | Kyunghee University Medical Center |
| Drug class | Antiplatelet agent / Anticoagulant |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
Loxonine functions as an antiplatelet and anticoagulant agent. Upon absorption, it is metabolized to an active metabolite that inhibits platelet function and reduces thrombotic risk. The exact molecular mechanism involves interference with platelet activation pathways, making it useful in cardiovascular and thromboembolic conditions.
Approved indications
- Thrombotic disorders
- Stroke prevention
- Peripheral arterial disease
Common side effects
- Bleeding
- Gastrointestinal disturbance
- Headache
Key clinical trials
- Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |